Skip to main content
. 2017 Dec 14;22(12):2221. doi: 10.3390/molecules22122221

Figure 3.

Figure 3

(a) 1-(phenylsulfonyl)spiro[indoline-3,3′-pyrrolidin]-2-one (17) superimposed onto the classical pharmacophore; (b) 1′-(phenylsulfonyl)spiro[indoline-3,3′-pyrrolidin]-2-one (18) fitting to the pharmacophore pattern lacking a positive ionisable moiety.